|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/397 | |
| A61K 9/06 | |||
| A61K 9/08 | |||
| A61P 35/00 | |||
| C07D 405/12 |
| (11) | Patento numeris | 3010502 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14813526.2 |
| Europos patento paraiškos padavimo data | 2014-06-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/043038 |
| Data | 2014-06-18 |
| (87) | Numeris | WO 2014/205136 |
| Data | 2014-12-24 |
| (30) | Numeris | Data | Šalis |
| 201361837091 P | 2013-06-19 | US | |
| 201461952651 P | 2014-03-13 | US |
| (72) |
GOVEK, Steven, P., US
KAHRAMAN, Mehmet, US
SMITH, Nicholas, D., US
HAGER, Jeffrey, H., US
CHOW MANEVAL, Edna, US
|
| (73) |
Seragon Pharmaceuticals, Inc.,
12780 El Camino Real, Suite 302, San Diego, CA 92130,
US
|
| (54) | AZETIDINE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF |
| AZETIDINE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF |